Temple Health has named Fox Chase Cancer Center as the new institutional home of the Robert A. Winn Excellence in Clinical Trials Award Program (Winn Awards), a national initiative that trains clinical research leaders and works to broaden participation in clinical trials, Fox Chase announced on November 16, 2026. The Bristol Myers Squibb Foundation (BMS Foundation), the program’s founding funder, has also renewed its support to fund cohorts through 2030.
“Breakthroughs in medicine only change lives when they reach the people who need them,” said Robert A. Winn, MD, the program’s namesake, National Advisory Committee Chair, and Cancer Center Director at Fox Chase.
Why the Program Moved to Fox Chase
The move follows Dr. Winn’s recent appointment as Cancer Center Director at Fox Chase. The cancer center will build on the program’s first five years while supporting collaboration among Winn Awards scholars, academic institutions, healthcare organizations, community partners, and funders.
“Expanding access to paradigm-shifting research and the clinical trials that drive innovation is at the heart of our mission,” said Robert Uzzo, MD, MBA, President and CEO of Fox Chase Cancer Center.
Along with the BMS Foundation, the program’s other funding partners, Gilead Sciences, Genentech, Amgen, and AstraZeneca, have committed to continue their support.
“The Winn Awards were built on a belief that better science requires broader research participation, and five years of success have shown that to be true,” said Catharine Grimes, President of the BMS Foundation.
Building the Next Generation of Clinical Researchers
The BMS Foundation created the Winn Awards in 2020 with a $100 million commitment. The program aims to ensure that the patients who take part in clinical trials reflect the populations most affected by the diseases being studied. Its curriculum covers research design, community engagement, and mentorship.
Since its launch, the program has funded 361 early-career physician investigators through its Winn Career Development Award, run with the American Association for Cancer Research (AACR), and 373 medical students through its Winn Clinical Investigator Pathway Program. It has also awarded 11 Gilead Sciences Community Innovation Grants and supported 18 Clinical Investigator Leadership Award scholars, through Conquer Cancer, the ASCO Foundation, and the American Heart Association. More than 90 institutions, 150 faculty members, and 300 mentors take part.
Fox Chase already has Winn alumni on staff. Christopher G. Cann, MD, director of the center’s Young Adult Cancer Program and assistant professor of hematology/oncology, was part of the program’s fifth cohort of Career Development Award scholars.
“The mentorship and support I received helped me think through how to structure our trials, identify meaningful outcomes and build something that could realistically improve care for young adults with cancer,” Dr. Cann said.
About Fox Chase Cancer Center
Fox Chase Cancer Center is a cancer research and treatment center in Philadelphia and part of Temple Health, which includes the Lewis Katz School of Medicine at Temple University.
Source: Fox Chase Cancer Center, https://www.foxchase.org/news/temple-health-welcomes-winn-awards-fox-chase-cancer-center-bristol-myers-squibb-foundation on November 16, 2026. Republished with credit to the original author. Read the original article.
Source: Fox Chase Cancer Center – Philadelphia PA on November 15, 2026. Republished with credit to the original author. Read the original release.